云南高校图书馆联盟文献共享服务平台- DABIGATRAN

DABIGATRAN: 作品数：34被引量：42H指数：4; 导出分析报告; 相关领域：医药卫生更多>>; 相关机构：北京大学中国药科大学更多>>; 相关期刊：《World Journal of Clinical Cases》《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》《Journal of Geriatric Cardiology》《Chinese Journal of Traumatology》更多>>; 相关基金：国家重点基础研究发展计划更多>>

Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation被引量：1: 《Journal of Geriatric Cardiology》2022年第8期565-574,共10页Qian XIN Chuang ZHANG Yu-Jia WANG Jian LI Tao CHEN Shi-Xing LI Wei WANG Yu YANG Wen-Juan SONG Jin ZHOU Xiang-Min SHI; supported by the Chinese PLA Special Research on Health Care (17BJZ08); BACKGROUND Uninterrupted use of oral anticoagulants before atrial fibrillation(AF)ablation can reduce the incidence of perioperative thromboembolic events.However,the effect of new oral anticoagulants on activated clo...; 关键词：PATIENTS HEPARIN DOSAGE

Dabigatran in cardiovascular disease management:A comprehensive review被引量：1: 《World Journal of Cardiology》2021年第12期710-719,共10页Ayesha Javed Muhammad Ajmal Aaron Wolfson; Dabigatran,a direct thrombin inhibitor,has robust data for the treatment of deep venous thrombosis and pulmonary embolism,stroke prevention in non-valvular atrial fibrillation,and the prophylaxis of venous thromboembo...; 关键词：DABIGATRAN ANTICOAGULATION THROMBUS BLEEDING Atrial fibrillation Deep venous thrombosis Stroke

Dabigatran,rivaroxaban,and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation:An updated metaanalysis被引量：5: 《World Journal of Cardiology》2021年第4期82-94,共13页Wei-Jia Li Paraschos Archontakis-Barakakis Leonidas Palaiodimos Dimitrios Kalaitzoglou Lazaros Tzelves Apostolos Manolopoulos Yu-Chiang Wang Stefanos Giannopoulos Robert Faillace Damianos G Kokkinidis; BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation(AF)originated from western countrie...; 关键词：Novel oral anticoagulant Direct oral anticoagulant Atrial fibrillation Asian population DABIGATRAN RIVAROXABAN APIXABAN WARFARIN

Association between estimated glomerular filtration rate and bleeding in elderly hypertensive patients complicated with non-valvular atrial fibrillation under dabigatran treatment: 《China Medical Abstracts(Internal Medicine)》2021年第1期31-32,共2页SHI Yumeng; Objective To investigate the relationship between estimated glomerular filtration rate (eGFR) and hemorrhage in elderly hypertensive patients complicated with non-valvular atrial fibrillation under dabigatran treatmen...; 关键词：HYPERTENSIVE patients FIBRILLATION

Association between body mass index and the risk of bleeding in elderly patients with non-valvular atrial fibrillation taking dabigatran:a cohort study被引量：2: 《Journal of Geriatric Cardiology》2020年第4期193-201,共9页Ming-Hui LI Li-Hua HU Yu-Rong XIONG Yu YU Wei ZHOU Tao WANG Ling-Juan ZHU Xi LIU Hui-Hui BAO Xiao-Shu CHENG; supported by the Major New Drug Creation Program from National Science and Technology Major Project of China(2014ZX09303305).; Background Uncertainty remains regarding the association between body mass index(BMI)and the risk of bleeding in patients with non-valvular atrial fibrillation(NVAF).We aimed to investigate the association between BMI...; 关键词：ATRIAL FIBRILLATION BLEEDING BODY mass index DABIGATRAN

Bleeding and clotting in hereditary hemorrhagic telangiectasia被引量：1: 《World Journal of Clinical Cases》2015年第4期330-337,共8页Christopher Dittus Michael Streiff Jack Ansell; Hereditary hemorrhagic telangiectasia(HHT) is arelatively common inherited vascular disorder that was first described in 1864, and is notable for epistaxis, telangiectasia, and arterial venous malformations. While gen...; 关键词：Anticoagulation Hereditary hemorrhagic TELANGIECTASIA Hemorrhage Thrombosis RIVAROXABAN APIXABAN DABIGATRAN WARFARIN

Clinical considerations of anticoagulation therapy for patients with atrial fibrillation被引量：1: 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》2012年第8期609-615,共7页Shu ZHANG; Project (No. 200902001) supported by the Research on Monitoring,Prevention, Early-Warning, Diagnosis,and Therapy of Cardiovascular Diseases Part Ⅱ:Community Based Approach for Atrial Fibrillation and Sudden Cardiac Death, China; Atrial fibrillation (AF) increases the risk of stroke. New anticoagulation agents have recently provided alternative and promising approaches. This paper reviews the current state of anticoagulation therapy in AF pati...; 关键词：Anticoagulation therapy Atrial fibrillation Warfarin DABIGATRAN Riveroxaban APIXABAN

Dabigatran预防心房颤动脑卒中的效果: 《中国心脏起搏与心电生理杂志》2010年第4期351-351,共1页余国膺; 关键词：心房颤动脑卒中直接凝血酶抑制剂预防华法林大出血

新型抗凝药Dabigatran或将成为华法林替代品用于治疗静脉血栓栓塞: 《药学进展》2010年第4期189-190,共2页; 关键词：DABIGATRAN 华法林直接凝血酶抑制剂静脉血栓栓塞

Dabigatran与华法林治疗VTE的对比结果: 《国外药讯》2010年第2期13-14,共2页; 在美国血液病学学会（ASH）新奥尔良会议上报告的RE—COVER研究结果显示，对急性静脉血栓栓塞（VTE）病人Boehringer—Ingelheim公司的Pradaxa（dabigatran）效果不亚于华法林。该公司称，它将在推进急性VTE治疗适应症之前把重点放在使...; 关键词：VTE 华法林治疗新奥尔良会议静脉血栓栓塞血液病学适应症急性

DABIGATRAN